4.5 Article

Hoiamide D, a marine cyanobacteria-derived inhibitor of p53/MDM2 interaction

期刊

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
卷 22, 期 1, 页码 683-688

出版社

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.bmcl.2011.10.054

关键词

Marine cyanobacteria; Natural products; Lipopeptide; Anticancer; Spectroscopy

资金

  1. NIH [CA 52955, NS 053398]
  2. NIH/NCI [CA100851]
  3. NATIONAL CANCER INSTITUTE [U19CA052955, U01CA052955, R01CA100851] Funding Source: NIH RePORTER
  4. NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS053398] Funding Source: NIH RePORTER

向作者/读者索取更多资源

Bioassay-guided fractionation of two cyanobacterial extracts from Papua New Guinea has yielded hoiamide D in both its carboxylic acid and conjugate base forms. Hoiamide D is a polyketide synthase (PKS)/non-ribosomal peptide synthetase (NRPS)-derived natural product that features two consecutive thiazolines and a thiazole, as well as a modified isoleucine residue. Hoiamide D displayed inhibitory activity against p53/MDM2 interaction (EC50 = 4.5 mu M), an attractive target for anticancer drug development. (C) 2011 Elsevier Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据